High Correlation among Brain-Derived Major Protein Levels in Cerebrospinal Fluid: Implication for Amyloid-Beta and Tau Protein Changes in Alzheimer's Disease (vol 12, 355, 2022)

被引：0
|
作者：
Hoshi, Kyoka [1 ]
Kanno, Mayumi [2 ]
Abe, Mitsunari [3 ,9 ]
Murakami, Takenobu [3 ,10 ]
Ugawa, Yoshikazu [3 ,11 ]
Goto, Aya [4 ]
Honda, Takashi [2 ]
Saito, Takashi [5 ,12 ]
Saido, Takaomi C. [5 ]
Yamaguchi, Yoshiki [6 ,13 ]
Miyajima, Masakazu [7 ]
Furukawa, Katsutoshi [8 ,14 ]
Arai, Hiroyuki [8 ]
Hashimoto, Yasuhiro [2 ]
机构：
[1] Fukushima Med Univ, Dept Biochem, Fukushima 9601295, Japan
[2] Fukushima Med Univ, Dept Forens Med, Fukushima 9601295, Japan
[3] Fukushima Med Univ, Dept Neurol, Fukushima 9601295, Japan
[4] Fukushima Med Univ, Ctr Integrated Sci & Humanities, Fukushima 9601295, Japan
[5] RIKEN Ctr Brain Sci, Lab Proteolyt Neurosci, Saitama 3510198, Japan
[6] RIKEN Global Res Cluster, Struct Glyocobiol Team, Saitama 3510198, Japan
[7] Juntendo Univ, Dept Neurosurg, Tokyo 1138421, Japan
[8] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan
[9] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Dept Adv Neuroimaging, Tokyo 1878551, Japan
[10] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neurol, Tottori 6838504, Japan
[11] Fukushima Med Univ, Dept Human Neurophysiol, Fukushima 9601295, Japan
[12] Nagoya City Univ, Dept Neurocognit Sci, Nagoya, Aichi 4678601, Japan
[13] Tohoku Med & Pharmaceut Univ, Lab Pharmaceut Phys Chem, Sendai, Miyagi 9818558, Japan
[14] Tohoku Med & Pharmaceut Univ, Div Community Med, Sendai, Miyagi 9818558, Japan
来源：
METABOLITES | 2023年 / 13卷 / 06期
关键词：
D O I：
10.3390/metabo13060685
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 15 条
  • [1] High Correlation among Brain-Derived Major Protein Levels in Cerebrospinal Fluid: Implication for Amyloid-Beta and Tau Protein Changes in Alzheimer's Disease
    Hoshi, Kyoka
    Kanno, Mayumi
    Abe, Mitsunari
    Murakami, Takenobu
    Ugawa, Yoshikazu
    Goto, Aya
    Honda, Takashi
    Saito, Takashi
    Saido, Takaomi C.
    Yamaguchi, Yoshiki
    Miyajima, Masakazu
    Furukawa, Katsutoshi
    Arai, Hiroyuki
    Hashimoto, Yasuhiro
    METABOLITES, 2022, 12 (04)
  • [2] Cerebrospinal fluid amyloid beta and tau protein: biomarkers for Alzheimer's disease
    Mandic, Gorana
    Markovic, Ivanka
    Ostojic, Marija
    Stojkovic, Tanja
    Misirlic-Dencic, Sonja
    Zivanovic-Radnic, Tatjana
    Stefanovic, Rodoljub
    Bumbasirevic, Marko
    Stefanova, Elka
    Kostic, Vladimir
    VOJNOSANITETSKI PREGLED, 2008, 65 (12) : 901 - 905
  • [3] Changes in cerebrospinal fluid levels of amyloid-beta protein in pediatric patients with severe brain trauma
    Ikonomovic, MD
    Abrahamson, EE
    Paljug, WR
    Hope, CE
    Kochonek, PM
    DeKosky, ST
    JOURNAL OF NEUROTRAUMA, 2004, 21 (09) : 1330 - 1330
  • [4] Cerebrospinal fluid levels of amyloid precursor protein and amyloid β-peptide in Alzheimer's disease and major depression -: inverse correlation with dementia severity
    Hock, C
    Golombowski, S
    Müller-Spahn, F
    Naser, W
    Beyreuther, K
    Mönning, U
    Schenk, D
    Vigo-Pelfrey, C
    Bush, AM
    Moir, R
    Tanzi, RE
    Growdon, JH
    Nitsch, RM
    EUROPEAN NEUROLOGY, 1998, 39 (02) : 111 - 118
  • [5] Plasma homocystein levels in relation to β Amyloid and Tau Protein in cerebrospinal fluid of patients with Mild Cognitive Impairment and Alzheimer's Disease
    Panagiotis Alexopoulos
    Florian Guenther
    Tanja Richter- Schmidinger
    Barbara Gruss
    Jens Wiltfang
    Stefan Bleich
    Johannes Kornhuber
    Annals of General Psychiatry, 7 (Suppl 1)
  • [6] Clinical use and analytical problems in amyloid-beta(1-42) and tau protein in cefalorachidic fluid as markers of Alzheimer's disease
    Kang, Ju-Hee
    Korecka, Magdalena
    Toledo, Jon B.
    Trojanowski, John Q.
    Shaw, Leslie M.
    BIOCHIMICA CLINICA, 2014, 38 (03) : 255 - 267
  • [7] Cerebrospinal fluid TAU protein and amyloid β42 in mild cognitive impairment:: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination
    Ivanoiu, A
    Sindic, CJM
    NEUROCASE, 2005, 11 (01) : 32 - 39
  • [8] Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein
    Lindh, M
    Blomberg, M
    Jensen, M
    Basun, H
    Lannfelt, L
    Engvall, B
    Scharnagel, H
    Marz, W
    Wahlund, LO
    Cowburn, RF
    NEUROSCIENCE LETTERS, 1997, 229 (02) : 85 - 88
  • [9] Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease - Correlations with amyloid load in the brain
    Pirttila, T
    Mehta, PD
    Soininen, H
    Kim, KS
    Heinonen, O
    Paljarvi, L
    Kosunen, O
    Riekkinen, P
    Wisniewski, HM
    ARCHIVES OF NEUROLOGY, 1996, 53 (02) : 189 - 193
  • [10] Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein
    Marksteiner, Josef
    Hinterhuber, Hartmann
    Humpel, Christian
    DRUGS OF TODAY, 2007, 43 (06) : 423 - 431
12